Westmount Partners LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,338 shares of the company’s stock, valued at approximately $494,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in Cardinal Health during the fourth quarter worth approximately $790,344,000. Wellington Management Group LLP increased its holdings in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Holocene Advisors LP increased its holdings in shares of Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock valued at $302,332,000 after buying an additional 1,128,358 shares in the last quarter. Marshall Wace LLP lifted its position in shares of Cardinal Health by 1,328.1% during the 4th quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock valued at $195,484,000 after acquiring an additional 884,648 shares during the last quarter. Finally, Barclays PLC lifted its position in shares of Cardinal Health by 109.3% during the 3rd quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after acquiring an additional 827,446 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on CAH shares. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Monday, June 15th. Morgan Stanley upped their target price on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Leerink Partners reiterated an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Robert W. Baird set a $248.00 price target on Cardinal Health in a research note on Friday, May 1st. Finally, Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average target price of $246.93.
Cardinal Health Stock Up 0.1%
Shares of NYSE:CAH opened at $222.08 on Friday. The company’s fifty day moving average is $204.34 and its two-hundred day moving average is $209.27. The company has a market cap of $52.01 billion, a P/E ratio of 33.96, a price-to-earnings-growth ratio of 1.21 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter last year, the firm posted $2.35 earnings per share. Cardinal Health’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.
Cardinal Health Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.19%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
